This inventor holds 55 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Metal-Catalyzed Reactions (CPC class C07D). Top assignees: Massachusetts Institute of Technology, Collegium Pharmaceutical, Inc., Whitehead Institute for Biomedical Research. Active years: 1991-2018.
Inventors with similar research interests:
Location History:
- Somerville, MA (US) (1991 - 1996)
- Newton, MA (US) (1998 - 2018)
Company Filing History:
51 out of 8,568 
4 out of 28 
3 out of 317 
Years Active: 1991-2018
Areas of Expertise:
Title: Stephen L. Buchwald: A Pioneer in Chemical Innovations
Introduction: Stephen L. Buchwald, based in Newton, MA, is a renowned inventor and researcher with an impressive portfolio of 55 patents. His innovative work primarily revolves around chemical transformations that enhance the field of biotechnology and materials science.
Latest Patents: Among his most recent patents, two notable inventions stand out. The first, "Selective arylation of dichalcogenides in biomolecules," discloses cutting-edge methods for the conjugation of unprotected peptide biomolecules. This invention offers significant advantages, particularly in the selective functionalization of cysteine and selenocysteine, providing superior specificity towards selenocysteine compared to other nucleophiles like amines and hydroxyls. Additionally, the process exhibits excellent functional group tolerance and operates under mild reaction conditions. The second patent involves "[2.2]paracyclophane-derived donor/acceptor-type molecules for OLED applications." This invention presents novel compounds and related polymers that serve as stable, efficient, blue-light emitting materials, advancing organic light-emitting diode (OLED) technology.
Career Highlights: Stephen L. Buchwald's distinguished career includes significant roles at prestigious institutions, notably the Massachusetts Institute of Technology (MIT) and Collegium Pharmaceutical, Inc. His work at MIT has established him as a leader in the field of chemical engineering, contributing to advancements that bridge academic research and practical applications.
Collaborations: Throughout his career, Buchwald has collaborated with talented individuals, including esteemed colleagues John P. Wolfe and Michael Palucki. These partnerships have fostered an environment of innovation and have led to several groundbreaking patents that continue to influence the scientific community.
Conclusion: Stephen L. Buchwald's contributions to chemical innovations reflect a commitment to advancing technology that benefits various industries. His extensive patent portfolio not only highlights his ingenuity but also underscores the importance of collaboration in scientific discovery. As innovations continue to emerge from his research, Buchwald remains a pivotal figure in the fields of chemistry and biotechnology.